Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,925 results for ""Cystadenocarcinoma, Serous""

Your Filters

Content Provider : MEDLINE
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

B cells critical for outcome in high grade serous ovarian carcinoma.

  • Authors : Vledder A; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Paijens ST

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/immunology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/mortality

  • Source: International journal of cancer [Int J Cancer] 2024 Dec 15; Vol. 155 (12), pp. 2265-2276. Date of Electronic Publication: 2024 Aug 22.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.

  • Authors : Morgan RD; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. .; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom. .

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: British journal of cancer [Br J Cancer] 2024 Dec; Vol. 131 (12), pp. 1919-1927. Date of Electronic Publication: 2024 Nov 16.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma.

  • Authors : Rushton T; Johns Hopkins University, Baltimore, MD, United States of America. Electronic address: .; Krause HB

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/metabolism

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 80-85. Date of Electronic Publication: 2024 Oct 03.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of ubiquitin-specific proteinase 43 on ovarian serous adenocarcinoma and its clinical significance.

  • Authors : Li Q; Department of Obstetrics and Gynecology, Lixin County People's Hospital, Bozhou, China.; Li W

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/metabolism ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology [J Obstet Gynaecol] 2024 Dec; Vol. 44 (1), pp. 2361862. Date of Electronic Publisher: Informa Healthcare Country of Publication: England NLM ID: 8309140 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.

  • Authors : Spear S; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom.

Subjects: PTEN Phosphohydrolase*/PTEN Phosphohydrolase*/PTEN Phosphohydrolase*/genetics ; PTEN Phosphohydrolase*/PTEN Phosphohydrolase*/PTEN Phosphohydrolase*/metabolism ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: Cancer research [Cancer Res] 2024 Nov 15; Vol. 84 (22), pp. 3772-3787.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions.

  • Authors : MacFawn IP; Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA; UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/immunology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics

  • Source: Cancer cell [Cancer Cell] 2024 Nov 11; Vol. 42 (11), pp. 1864-1881.e5. Date of Electronic Publication: 2024 Oct 10.Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma.

Subjects: Tumor Microenvironment*/Tumor Microenvironment*/Tumor Microenvironment*/immunology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/immunology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: Cancer immunology research [Cancer Immunol Res] 2024 Nov 04; Vol. 12 (11), pp. 1492-1507.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Developing a DNA Methylation Signature to Differentiate High-Grade Serous Ovarian Carcinomas from Benign Ovarian Tumors.

  • Authors : Oliveira DVNP; Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Biskup E

Subjects: DNA Methylation* ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/diagnosis

  • Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2024 Nov; Vol. 28 (6), pp. 821-834. Date of Electronic Publication: 2024 Oct 16.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer.

  • Authors : Peters PN; Duke University Department of Obstetrics and Gynecology. Electronic address: .; Whitaker RS

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/immunology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Nov; Vol. 57, pp. 101056. Date of Electronic Publication: 2024 Sep 13.Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Molecular classification of ovarian high-grade serous/endometrioid carcinomas through multi-omics analysis: JGOG3025-TR2 study.

  • Authors : Takamatsu S; Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/classification

  • Source: British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (8), pp. 1340-1349. Date of Electronic Publication: 2024 Aug 30.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  4,925 results for ""Cystadenocarcinoma, Serous""